...
首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival (published erratum appears in Nephrol Dial Transplant 1998 May;13(5):1328)
【24h】

Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival (published erratum appears in Nephrol Dial Transplant 1998 May;13(5):1328)

机译:系统性红斑狼疮中的肾血栓性微血管病:临床相关性和长期肾脏存活(发表的勘误表见《 Nephrol Dial Transplant》 1998年5月; 13(5):1328)

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Renal thrombotic microangiopathy (TMA) is an uncommon vascular complication of systemic lupus erythematosus (SLE). Its clinical symptoms and impact on renal survival remain unclear. METHODS: Eight patients aged 25 +/- 6 years with biopsy-proven renal TMA and at least four ARA criteria for the diagnosis of SLE were retrospectively studied over a 7-year period. RESULTS: All patients presented with renal failure (creatinine 3.3 +/- 2.1 mg/dl), six had proteinuria (2.5 +/- 1.3 g/day) with microscopic haematuria in four cases. Six patients had hypertension, which was severe in five cases. Renal histology disclosed arterial and/or arteriolar thrombosis with parietal thickening without angeitis (8 patients), glomerular microthrombi (3 patients), and vascular fibrin deposits (5/6 patients). In two cases, vascular lesions were associated with a mesangial or a proliferative glomerulonephritis. Thrombocytopenia was present in four patients with haemolytic microangiopathic anaemia in one case. Lupus anticoagulant (LA) was detected in five of eight patients, who also had anticardiolipin antibodies (3/7 patients) and/or were positive for VDRL (3/6 patients). Four patients with LA experienced arterial thrombosis and/or repeated spontaneous abortions. Treatment consisted of corticosteroids (8 patients), cytotoxic drugs (4 patients), plasma exchanges and/or intravenous immunoglobulins (4 patients) and antiplatelet and/or anticoagulant therapy (3 patients). Two patients recovered normal renal function and five had persistent renal insufficiency. One patient started haemodialysis on admission and died of sepsis 2 months later. CONCLUSIONS: TMA may be the sole renal complication in SLE and is not usually associated with haemolytic microangiopathic anaemia. In our series renal survival was influenced by the extent and severity of vascular lesions. Despite a frequent association with antiphospholipid antibodies, pathophysiological mechanisms of renal TMA in SLE remain unknown. Renal histology is mandatory for the diagnosis and the prognostic evaluation of renal vasculopathy in SLE.
机译:背景:肾血栓性微血管病(TMA)是系统性红斑狼疮(SLE)的罕见血管并发症。其临床症状及其对肾存活的影响尚不清楚。方法:回顾性研究了7例年龄25 +/- 6岁,经活检证实的肾脏TMA和至少4项ARA标准诊断SLE的患者。结果:所有患者均出现肾功能衰竭(肌酐3.3 +/- 2.1 mg / dl),其中6例患有蛋白尿(2.5 +/- 1.3 g /天),并伴有镜下血尿4例。六例患者患有高血压,其中五例严重。肾脏组织学发现动脉和/或小动脉血栓形成伴壁厚增厚,无血管炎(8例),肾小球微血栓(3例)和血管纤维蛋白沉积(5/6例)。在两种情况下,血管病变与肾小球膜或增生性肾小球肾炎有关。溶血性微血管性贫血的四例患者中有血小板减少症,一例。在八名患者中的五名中检测到狼疮抗凝剂(LA),他们也有抗心磷脂抗体(3/7例)和/或VDRL阳性(3/6例)。四名LA患者经历了动脉血栓形成和/或反复自然流产。治疗包括皮质类固醇(8例),细胞毒性药物(4例),血浆置换和/或静脉内免疫球蛋白(4例)以及抗血小板和/或抗凝治疗(3例)。 2例患者肾功能恢复正常,5例患者持续存在肾功能不全。一名患者入院时开始血液透析,两个月后死于败血症。结论:TMA可能是SLE的唯一肾脏并发症,通常与溶血性微血管性贫血无关。在我们的系列研究中,肾脏存活率受到血管病变程度和严重程度的影响。尽管经常与抗磷脂抗体相关联,但SLE中肾脏TMA的病理生理机制仍然未知。肾组织学对于SLE肾血管病变的诊断和预后评估是必不可少的。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号